PKM and cancer: Furthermore, two isoforms of Pyruvate kinase (PKM) (isoform M1 and isoform M2) were differentially co-expressed with a high PKM2/PKM1 ratio supporting aerobic glycolysis (a hallmark feature of cancer) at the expense of oxidative phosphorylation (most likely inefficient due to the disruption of the ETC).